Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(Early phase clinical drug development). Showing records 1 – 30 of 129546 total matches.

[1] [2] [3] [4] [5] … [4319]

Search Limiters

Last 2 Years | English Only

Degrees

Languages

Country

▼ Search Limiters

1. Martinez, Jean-Marie. Contribution de l'approche de pharmacocinétique de population au développement clinique des médicaments : application aux données de phase III : Contribution of pharmacokinetic population approach to clinical drug development : application to phase III data.

Degree: Docteur es, Sciences du médicament, 2010, Université Montpellier I

Par l'utilisation de techniques statistiques poussées, l'approche de population rend l'estimation des propriétés pharmacocinétiques (étude des phénomènes d'absorption, distribution, métabolisme et élimination du médicament dans… (more)

Subjects/Keywords: Pharmacocinétique; Population; Développement clinique; Phase III; Pharmacokinetics; Population; Clinical Drug Development; Phase III

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Martinez, J. (2010). Contribution de l'approche de pharmacocinétique de population au développement clinique des médicaments : application aux données de phase III : Contribution of pharmacokinetic population approach to clinical drug development : application to phase III data. (Doctoral Dissertation). Université Montpellier I. Retrieved from http://www.theses.fr/2010MON13511

Chicago Manual of Style (16th Edition):

Martinez, Jean-Marie. “Contribution de l'approche de pharmacocinétique de population au développement clinique des médicaments : application aux données de phase III : Contribution of pharmacokinetic population approach to clinical drug development : application to phase III data.” 2010. Doctoral Dissertation, Université Montpellier I. Accessed April 18, 2021. http://www.theses.fr/2010MON13511.

MLA Handbook (7th Edition):

Martinez, Jean-Marie. “Contribution de l'approche de pharmacocinétique de population au développement clinique des médicaments : application aux données de phase III : Contribution of pharmacokinetic population approach to clinical drug development : application to phase III data.” 2010. Web. 18 Apr 2021.

Vancouver:

Martinez J. Contribution de l'approche de pharmacocinétique de population au développement clinique des médicaments : application aux données de phase III : Contribution of pharmacokinetic population approach to clinical drug development : application to phase III data. [Internet] [Doctoral dissertation]. Université Montpellier I; 2010. [cited 2021 Apr 18]. Available from: http://www.theses.fr/2010MON13511.

Council of Science Editors:

Martinez J. Contribution de l'approche de pharmacocinétique de population au développement clinique des médicaments : application aux données de phase III : Contribution of pharmacokinetic population approach to clinical drug development : application to phase III data. [Doctoral Dissertation]. Université Montpellier I; 2010. Available from: http://www.theses.fr/2010MON13511


Universiteit Utrecht

2. Boss, D.S. Safety, pharmacokinetics and pharmacodynamics of targeted anti-cancer drugs.

Degree: 2009, Universiteit Utrecht

 With the emergence of novel, rationally designed anti-cancer drugs there is also a need for novel endpoints when evaluating these drugs in clinical trials. The… (more)

Subjects/Keywords: Farmacie; Drug Development; PET/CT; Phase I studies; Pharmacokinetics; Pharmacodynamics; Clinical trials; Cancer; Targeted therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Boss, D. S. (2009). Safety, pharmacokinetics and pharmacodynamics of targeted anti-cancer drugs. (Doctoral Dissertation). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/37369

Chicago Manual of Style (16th Edition):

Boss, D S. “Safety, pharmacokinetics and pharmacodynamics of targeted anti-cancer drugs.” 2009. Doctoral Dissertation, Universiteit Utrecht. Accessed April 18, 2021. http://dspace.library.uu.nl:8080/handle/1874/37369.

MLA Handbook (7th Edition):

Boss, D S. “Safety, pharmacokinetics and pharmacodynamics of targeted anti-cancer drugs.” 2009. Web. 18 Apr 2021.

Vancouver:

Boss DS. Safety, pharmacokinetics and pharmacodynamics of targeted anti-cancer drugs. [Internet] [Doctoral dissertation]. Universiteit Utrecht; 2009. [cited 2021 Apr 18]. Available from: http://dspace.library.uu.nl:8080/handle/1874/37369.

Council of Science Editors:

Boss DS. Safety, pharmacokinetics and pharmacodynamics of targeted anti-cancer drugs. [Doctoral Dissertation]. Universiteit Utrecht; 2009. Available from: http://dspace.library.uu.nl:8080/handle/1874/37369


Leiden University

3. Kolk, T. van der. Investigations of skin inflammation with a novel dermatology toolbox for early phase clinical drug development.

Degree: 2021, Leiden University

 <table><tbody><tr><td> In this thesis, a new approach for rational drug development in inflammatory skin disease was described by focusing on three important cornerstones: I) developing… (more)

Subjects/Keywords: Skin inflammation; Dermatology toolbox; Early phase clinical drug development; Trial at home; Inflammation models; Skin microbiome; Atopic dermatitis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kolk, T. v. d. (2021). Investigations of skin inflammation with a novel dermatology toolbox for early phase clinical drug development. (Doctoral Dissertation). Leiden University. Retrieved from http://hdl.handle.net/1887/3152427

Chicago Manual of Style (16th Edition):

Kolk, T van der. “Investigations of skin inflammation with a novel dermatology toolbox for early phase clinical drug development.” 2021. Doctoral Dissertation, Leiden University. Accessed April 18, 2021. http://hdl.handle.net/1887/3152427.

MLA Handbook (7th Edition):

Kolk, T van der. “Investigations of skin inflammation with a novel dermatology toolbox for early phase clinical drug development.” 2021. Web. 18 Apr 2021.

Vancouver:

Kolk Tvd. Investigations of skin inflammation with a novel dermatology toolbox for early phase clinical drug development. [Internet] [Doctoral dissertation]. Leiden University; 2021. [cited 2021 Apr 18]. Available from: http://hdl.handle.net/1887/3152427.

Council of Science Editors:

Kolk Tvd. Investigations of skin inflammation with a novel dermatology toolbox for early phase clinical drug development. [Doctoral Dissertation]. Leiden University; 2021. Available from: http://hdl.handle.net/1887/3152427


Harvard University

4. Santos, Dusica. Evaluation of Project Management in Early-Drug Discovery in Pharmaceutical Industry: Understanding the Cost and Benefit of Early Assignments of Project Managers.

Degree: 2019, Harvard University

The main purpose of this study is to evaluate the Project Management in early-Drug Discovery in the Pharmaceutical Industry and to examine the cost and… (more)

Subjects/Keywords: Project Management; Project Manager, Pharmaceutical Industry; early Drug Discovery; Drug Discovery and Development; R&D

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Santos, D. (2019). Evaluation of Project Management in Early-Drug Discovery in Pharmaceutical Industry: Understanding the Cost and Benefit of Early Assignments of Project Managers. (Thesis). Harvard University. Retrieved from http://nrs.harvard.edu/urn-3:HUL.InstRepos:42004196

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Santos, Dusica. “Evaluation of Project Management in Early-Drug Discovery in Pharmaceutical Industry: Understanding the Cost and Benefit of Early Assignments of Project Managers.” 2019. Thesis, Harvard University. Accessed April 18, 2021. http://nrs.harvard.edu/urn-3:HUL.InstRepos:42004196.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Santos, Dusica. “Evaluation of Project Management in Early-Drug Discovery in Pharmaceutical Industry: Understanding the Cost and Benefit of Early Assignments of Project Managers.” 2019. Web. 18 Apr 2021.

Vancouver:

Santos D. Evaluation of Project Management in Early-Drug Discovery in Pharmaceutical Industry: Understanding the Cost and Benefit of Early Assignments of Project Managers. [Internet] [Thesis]. Harvard University; 2019. [cited 2021 Apr 18]. Available from: http://nrs.harvard.edu/urn-3:HUL.InstRepos:42004196.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Santos D. Evaluation of Project Management in Early-Drug Discovery in Pharmaceutical Industry: Understanding the Cost and Benefit of Early Assignments of Project Managers. [Thesis]. Harvard University; 2019. Available from: http://nrs.harvard.edu/urn-3:HUL.InstRepos:42004196

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Harvard University

5. Santos, Dusica. Evaluation of Project Management in Early-Drug Discovery in Pharmaceutical Industry: Understanding the Cost and Benefit of Early Assignments of Project Managers.

Degree: ALM, 2019, Harvard University

The main purpose of this study is to evaluate the Project Management in early-Drug Discovery in the Pharmaceutical Industry and to examine the cost and… (more)

Subjects/Keywords: Project Management; Project Manager, Pharmaceutical Industry; early Drug Discovery; Drug Discovery and Development; R&D

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Santos, D. (2019). Evaluation of Project Management in Early-Drug Discovery in Pharmaceutical Industry: Understanding the Cost and Benefit of Early Assignments of Project Managers. (Masters Thesis). Harvard University. Retrieved from http://nrs.harvard.edu/urn-3:HUL.InstRepos:42004233

Chicago Manual of Style (16th Edition):

Santos, Dusica. “Evaluation of Project Management in Early-Drug Discovery in Pharmaceutical Industry: Understanding the Cost and Benefit of Early Assignments of Project Managers.” 2019. Masters Thesis, Harvard University. Accessed April 18, 2021. http://nrs.harvard.edu/urn-3:HUL.InstRepos:42004233.

MLA Handbook (7th Edition):

Santos, Dusica. “Evaluation of Project Management in Early-Drug Discovery in Pharmaceutical Industry: Understanding the Cost and Benefit of Early Assignments of Project Managers.” 2019. Web. 18 Apr 2021.

Vancouver:

Santos D. Evaluation of Project Management in Early-Drug Discovery in Pharmaceutical Industry: Understanding the Cost and Benefit of Early Assignments of Project Managers. [Internet] [Masters thesis]. Harvard University; 2019. [cited 2021 Apr 18]. Available from: http://nrs.harvard.edu/urn-3:HUL.InstRepos:42004233.

Council of Science Editors:

Santos D. Evaluation of Project Management in Early-Drug Discovery in Pharmaceutical Industry: Understanding the Cost and Benefit of Early Assignments of Project Managers. [Masters Thesis]. Harvard University; 2019. Available from: http://nrs.harvard.edu/urn-3:HUL.InstRepos:42004233


Leiden University

6. Dillingh, M.R. Clinical pharmacology of immuno-modulatory biotherapeutics : innovations in early drug development.

Degree: 2017, Leiden University

  Currently, a large number of pharmaceutical companies focus on the development of (immunomodulatory) biotherapeutics such as recombinant proteins and monoclonal antibodies, developed for therapeutic… (more)

Subjects/Keywords: Biotherapeutics; Early drug development

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Dillingh, M. R. (2017). Clinical pharmacology of immuno-modulatory biotherapeutics : innovations in early drug development. (Doctoral Dissertation). Leiden University. Retrieved from http://hdl.handle.net/1887/59458

Chicago Manual of Style (16th Edition):

Dillingh, M R. “Clinical pharmacology of immuno-modulatory biotherapeutics : innovations in early drug development.” 2017. Doctoral Dissertation, Leiden University. Accessed April 18, 2021. http://hdl.handle.net/1887/59458.

MLA Handbook (7th Edition):

Dillingh, M R. “Clinical pharmacology of immuno-modulatory biotherapeutics : innovations in early drug development.” 2017. Web. 18 Apr 2021.

Vancouver:

Dillingh MR. Clinical pharmacology of immuno-modulatory biotherapeutics : innovations in early drug development. [Internet] [Doctoral dissertation]. Leiden University; 2017. [cited 2021 Apr 18]. Available from: http://hdl.handle.net/1887/59458.

Council of Science Editors:

Dillingh MR. Clinical pharmacology of immuno-modulatory biotherapeutics : innovations in early drug development. [Doctoral Dissertation]. Leiden University; 2017. Available from: http://hdl.handle.net/1887/59458


University of Waterloo

7. Looby, Nikita. Therapeutic drug monitoring, clinical metabolomics and pharmacometabolomics via solid phase microextraction (SPME): The first step towards an alternative rapid diagnostic tool.

Degree: 2020, University of Waterloo

 Personalized medicine is a branch of medicine that focuses on how a prescribed therapeutic treatment affects a specific individual as opposed to its general effects… (more)

Subjects/Keywords: solid phase microextraction; therapeutic drug monitoring; rapid diagnostics; clinical metabolomics; in vivo analysis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Looby, N. (2020). Therapeutic drug monitoring, clinical metabolomics and pharmacometabolomics via solid phase microextraction (SPME): The first step towards an alternative rapid diagnostic tool. (Thesis). University of Waterloo. Retrieved from http://hdl.handle.net/10012/15892

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Looby, Nikita. “Therapeutic drug monitoring, clinical metabolomics and pharmacometabolomics via solid phase microextraction (SPME): The first step towards an alternative rapid diagnostic tool.” 2020. Thesis, University of Waterloo. Accessed April 18, 2021. http://hdl.handle.net/10012/15892.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Looby, Nikita. “Therapeutic drug monitoring, clinical metabolomics and pharmacometabolomics via solid phase microextraction (SPME): The first step towards an alternative rapid diagnostic tool.” 2020. Web. 18 Apr 2021.

Vancouver:

Looby N. Therapeutic drug monitoring, clinical metabolomics and pharmacometabolomics via solid phase microextraction (SPME): The first step towards an alternative rapid diagnostic tool. [Internet] [Thesis]. University of Waterloo; 2020. [cited 2021 Apr 18]. Available from: http://hdl.handle.net/10012/15892.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Looby N. Therapeutic drug monitoring, clinical metabolomics and pharmacometabolomics via solid phase microextraction (SPME): The first step towards an alternative rapid diagnostic tool. [Thesis]. University of Waterloo; 2020. Available from: http://hdl.handle.net/10012/15892

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Universiteit Utrecht

8. Leijen, S. Development of Combination Therapy with Anti-Cancer Drugs.

Degree: 2013, Universiteit Utrecht

 This thesis describes early clinical trials with anti-cancer drugs in combination with commonly applied and registered chemotherapy and single agent studies with compounds that are… (more)

Subjects/Keywords: Farmacie; Drug development; Cancer; Clinical trial; Pharmacokinetics; Pharmacodynamics; Chemotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Leijen, S. (2013). Development of Combination Therapy with Anti-Cancer Drugs. (Doctoral Dissertation). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/267996

Chicago Manual of Style (16th Edition):

Leijen, S. “Development of Combination Therapy with Anti-Cancer Drugs.” 2013. Doctoral Dissertation, Universiteit Utrecht. Accessed April 18, 2021. http://dspace.library.uu.nl:8080/handle/1874/267996.

MLA Handbook (7th Edition):

Leijen, S. “Development of Combination Therapy with Anti-Cancer Drugs.” 2013. Web. 18 Apr 2021.

Vancouver:

Leijen S. Development of Combination Therapy with Anti-Cancer Drugs. [Internet] [Doctoral dissertation]. Universiteit Utrecht; 2013. [cited 2021 Apr 18]. Available from: http://dspace.library.uu.nl:8080/handle/1874/267996.

Council of Science Editors:

Leijen S. Development of Combination Therapy with Anti-Cancer Drugs. [Doctoral Dissertation]. Universiteit Utrecht; 2013. Available from: http://dspace.library.uu.nl:8080/handle/1874/267996


Universiteit Utrecht

9. van Hasselt, J.G.C. Integrated quantitative pharmacology for treatment optimization in oncology.

Degree: 2014, Universiteit Utrecht

 This thesis describes the development and application of quantitative pharmacological models in oncology for treatment optimization and for the design and analysis of clinical trials… (more)

Subjects/Keywords: pharmacokinetics; pharmacodynamics; oncology; clinical pharmacology; modelling; pharmacometrics; special populations; drug development

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

van Hasselt, J. G. C. (2014). Integrated quantitative pharmacology for treatment optimization in oncology. (Doctoral Dissertation). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/309225

Chicago Manual of Style (16th Edition):

van Hasselt, J G C. “Integrated quantitative pharmacology for treatment optimization in oncology.” 2014. Doctoral Dissertation, Universiteit Utrecht. Accessed April 18, 2021. http://dspace.library.uu.nl:8080/handle/1874/309225.

MLA Handbook (7th Edition):

van Hasselt, J G C. “Integrated quantitative pharmacology for treatment optimization in oncology.” 2014. Web. 18 Apr 2021.

Vancouver:

van Hasselt JGC. Integrated quantitative pharmacology for treatment optimization in oncology. [Internet] [Doctoral dissertation]. Universiteit Utrecht; 2014. [cited 2021 Apr 18]. Available from: http://dspace.library.uu.nl:8080/handle/1874/309225.

Council of Science Editors:

van Hasselt JGC. Integrated quantitative pharmacology for treatment optimization in oncology. [Doctoral Dissertation]. Universiteit Utrecht; 2014. Available from: http://dspace.library.uu.nl:8080/handle/1874/309225

10. Boss, D.S. Safety, pharmacokinetics and pharmacodynamics of targeted anti-cancer drugs.

Degree: 2009, University Utrecht

 With the emergence of novel, rationally designed anti-cancer drugs there is also a need for novel endpoints when evaluating these drugs in clinical trials. The… (more)

Subjects/Keywords: Drug Development; PET/CT; Phase I studies; Pharmacokinetics; Pharmacodynamics; Clinical trials; Cancer; Targeted therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Boss, D. S. (2009). Safety, pharmacokinetics and pharmacodynamics of targeted anti-cancer drugs. (Doctoral Dissertation). University Utrecht. Retrieved from https://dspace.library.uu.nl/handle/1874/37369 ; URN:NBN:NL:UI:10-1874-37369 ; 1874/37369 ; urn:isbn:9789490122643 ; URN:NBN:NL:UI:10-1874-37369 ; https://dspace.library.uu.nl/handle/1874/37369

Chicago Manual of Style (16th Edition):

Boss, D S. “Safety, pharmacokinetics and pharmacodynamics of targeted anti-cancer drugs.” 2009. Doctoral Dissertation, University Utrecht. Accessed April 18, 2021. https://dspace.library.uu.nl/handle/1874/37369 ; URN:NBN:NL:UI:10-1874-37369 ; 1874/37369 ; urn:isbn:9789490122643 ; URN:NBN:NL:UI:10-1874-37369 ; https://dspace.library.uu.nl/handle/1874/37369.

MLA Handbook (7th Edition):

Boss, D S. “Safety, pharmacokinetics and pharmacodynamics of targeted anti-cancer drugs.” 2009. Web. 18 Apr 2021.

Vancouver:

Boss DS. Safety, pharmacokinetics and pharmacodynamics of targeted anti-cancer drugs. [Internet] [Doctoral dissertation]. University Utrecht; 2009. [cited 2021 Apr 18]. Available from: https://dspace.library.uu.nl/handle/1874/37369 ; URN:NBN:NL:UI:10-1874-37369 ; 1874/37369 ; urn:isbn:9789490122643 ; URN:NBN:NL:UI:10-1874-37369 ; https://dspace.library.uu.nl/handle/1874/37369.

Council of Science Editors:

Boss DS. Safety, pharmacokinetics and pharmacodynamics of targeted anti-cancer drugs. [Doctoral Dissertation]. University Utrecht; 2009. Available from: https://dspace.library.uu.nl/handle/1874/37369 ; URN:NBN:NL:UI:10-1874-37369 ; 1874/37369 ; urn:isbn:9789490122643 ; URN:NBN:NL:UI:10-1874-37369 ; https://dspace.library.uu.nl/handle/1874/37369

11. Zhang, Liangcai. Statistics Applications and Innovative Bayesian Statistics Modeling for Precision Medicine in Human Cancer Genomics and Clinical Trials.

Degree: PhD, Engineering, 2018, Rice University

 Human cancers are caused by aberrations of multiple biomarkers, and thus the pathogenesis is very complex and inconclusive in terms of individual variability in mutations,… (more)

Subjects/Keywords: Bioinformatics; Integrative analysis of cancer genomics; Biomarker identification; Biostatistics; Early phase clinical trials; Biomarker-based designs; Precision medicine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Zhang, L. (2018). Statistics Applications and Innovative Bayesian Statistics Modeling for Precision Medicine in Human Cancer Genomics and Clinical Trials. (Doctoral Dissertation). Rice University. Retrieved from http://hdl.handle.net/1911/105715

Chicago Manual of Style (16th Edition):

Zhang, Liangcai. “Statistics Applications and Innovative Bayesian Statistics Modeling for Precision Medicine in Human Cancer Genomics and Clinical Trials.” 2018. Doctoral Dissertation, Rice University. Accessed April 18, 2021. http://hdl.handle.net/1911/105715.

MLA Handbook (7th Edition):

Zhang, Liangcai. “Statistics Applications and Innovative Bayesian Statistics Modeling for Precision Medicine in Human Cancer Genomics and Clinical Trials.” 2018. Web. 18 Apr 2021.

Vancouver:

Zhang L. Statistics Applications and Innovative Bayesian Statistics Modeling for Precision Medicine in Human Cancer Genomics and Clinical Trials. [Internet] [Doctoral dissertation]. Rice University; 2018. [cited 2021 Apr 18]. Available from: http://hdl.handle.net/1911/105715.

Council of Science Editors:

Zhang L. Statistics Applications and Innovative Bayesian Statistics Modeling for Precision Medicine in Human Cancer Genomics and Clinical Trials. [Doctoral Dissertation]. Rice University; 2018. Available from: http://hdl.handle.net/1911/105715


University of Oregon

12. Wright, Dorianne. Evaluating the Effects of a Child-Focused Water, Sanitation, and Hygiene (WASH) Intervention in Laos.

Degree: PhD, Department of Psychology, 2020, University of Oregon

 Young children living in poverty in low- and middle-income countries are more likely to experience undernutrition, infectious diseases, environmental contaminants, and unstimulating surroundings. Exposure to… (more)

Subjects/Keywords: Child development; Clinical psychology; Early intervention; Global health; Parenting; Water; sanitation; hygiene

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wright, D. (2020). Evaluating the Effects of a Child-Focused Water, Sanitation, and Hygiene (WASH) Intervention in Laos. (Doctoral Dissertation). University of Oregon. Retrieved from https://scholarsbank.uoregon.edu/xmlui/handle/1794/25579

Chicago Manual of Style (16th Edition):

Wright, Dorianne. “Evaluating the Effects of a Child-Focused Water, Sanitation, and Hygiene (WASH) Intervention in Laos.” 2020. Doctoral Dissertation, University of Oregon. Accessed April 18, 2021. https://scholarsbank.uoregon.edu/xmlui/handle/1794/25579.

MLA Handbook (7th Edition):

Wright, Dorianne. “Evaluating the Effects of a Child-Focused Water, Sanitation, and Hygiene (WASH) Intervention in Laos.” 2020. Web. 18 Apr 2021.

Vancouver:

Wright D. Evaluating the Effects of a Child-Focused Water, Sanitation, and Hygiene (WASH) Intervention in Laos. [Internet] [Doctoral dissertation]. University of Oregon; 2020. [cited 2021 Apr 18]. Available from: https://scholarsbank.uoregon.edu/xmlui/handle/1794/25579.

Council of Science Editors:

Wright D. Evaluating the Effects of a Child-Focused Water, Sanitation, and Hygiene (WASH) Intervention in Laos. [Doctoral Dissertation]. University of Oregon; 2020. Available from: https://scholarsbank.uoregon.edu/xmlui/handle/1794/25579


Universiteit Utrecht

13. Hasselt, J.G.C. van. Integrated quantitative pharmacology for treatment optimization in oncology.

Degree: 2014, Universiteit Utrecht

 This thesis describes the development and application of quantitative pharmacological models in oncology for treatment optimization and for the design and analysis of clinical trials… (more)

Subjects/Keywords: Farmacie; pharmacokinetics; pharmacodynamics; oncology; clinical pharmacology; modelling; harmacometrics; special populations; drug development

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hasselt, J. G. C. v. (2014). Integrated quantitative pharmacology for treatment optimization in oncology. (Doctoral Dissertation). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/288569

Chicago Manual of Style (16th Edition):

Hasselt, J G C van. “Integrated quantitative pharmacology for treatment optimization in oncology.” 2014. Doctoral Dissertation, Universiteit Utrecht. Accessed April 18, 2021. http://dspace.library.uu.nl:8080/handle/1874/288569.

MLA Handbook (7th Edition):

Hasselt, J G C van. “Integrated quantitative pharmacology for treatment optimization in oncology.” 2014. Web. 18 Apr 2021.

Vancouver:

Hasselt JGCv. Integrated quantitative pharmacology for treatment optimization in oncology. [Internet] [Doctoral dissertation]. Universiteit Utrecht; 2014. [cited 2021 Apr 18]. Available from: http://dspace.library.uu.nl:8080/handle/1874/288569.

Council of Science Editors:

Hasselt JGCv. Integrated quantitative pharmacology for treatment optimization in oncology. [Doctoral Dissertation]. Universiteit Utrecht; 2014. Available from: http://dspace.library.uu.nl:8080/handle/1874/288569

14. Matheny, Jason Gaverick. The Economics of Pharmaceutical Development: Costs, Risks, and Incentives.

Degree: 2013, Johns Hopkins University

 This dissertation addresses three open questions related to the economics of pharmaceutical development. First, how much does it cost to conduct a clinical trial? Second,… (more)

Subjects/Keywords: health economics; pharmacoeconomics; econometrics; research and development; regression discontinuity design; Orphan Drug Act; clinical trials

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Matheny, J. G. (2013). The Economics of Pharmaceutical Development: Costs, Risks, and Incentives. (Thesis). Johns Hopkins University. Retrieved from http://jhir.library.jhu.edu/handle/1774.2/37064

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Matheny, Jason Gaverick. “The Economics of Pharmaceutical Development: Costs, Risks, and Incentives.” 2013. Thesis, Johns Hopkins University. Accessed April 18, 2021. http://jhir.library.jhu.edu/handle/1774.2/37064.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Matheny, Jason Gaverick. “The Economics of Pharmaceutical Development: Costs, Risks, and Incentives.” 2013. Web. 18 Apr 2021.

Vancouver:

Matheny JG. The Economics of Pharmaceutical Development: Costs, Risks, and Incentives. [Internet] [Thesis]. Johns Hopkins University; 2013. [cited 2021 Apr 18]. Available from: http://jhir.library.jhu.edu/handle/1774.2/37064.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Matheny JG. The Economics of Pharmaceutical Development: Costs, Risks, and Incentives. [Thesis]. Johns Hopkins University; 2013. Available from: http://jhir.library.jhu.edu/handle/1774.2/37064

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Rutgers University

15. Tsai, Pei-Chin, 1984-. Development of three dimensional human skin equivalents based on decellularized extracellular matrices and tyrosine-derived polycarbonate polymers for in-vitro drug screening applications.

Degree: PhD, Pharmaceutical Science, 2016, Rutgers University

Three-dimensional (3D) human skin equivalents (HSEs) are in-vitro models that have morphology and function similar to native human skin. Traditionally, drug discovery for lead compounds… (more)

Subjects/Keywords: Drug development

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tsai, Pei-Chin, 1. (2016). Development of three dimensional human skin equivalents based on decellularized extracellular matrices and tyrosine-derived polycarbonate polymers for in-vitro drug screening applications. (Doctoral Dissertation). Rutgers University. Retrieved from https://rucore.libraries.rutgers.edu/rutgers-lib/50236/

Chicago Manual of Style (16th Edition):

Tsai, Pei-Chin, 1984-. “Development of three dimensional human skin equivalents based on decellularized extracellular matrices and tyrosine-derived polycarbonate polymers for in-vitro drug screening applications.” 2016. Doctoral Dissertation, Rutgers University. Accessed April 18, 2021. https://rucore.libraries.rutgers.edu/rutgers-lib/50236/.

MLA Handbook (7th Edition):

Tsai, Pei-Chin, 1984-. “Development of three dimensional human skin equivalents based on decellularized extracellular matrices and tyrosine-derived polycarbonate polymers for in-vitro drug screening applications.” 2016. Web. 18 Apr 2021.

Vancouver:

Tsai, Pei-Chin 1. Development of three dimensional human skin equivalents based on decellularized extracellular matrices and tyrosine-derived polycarbonate polymers for in-vitro drug screening applications. [Internet] [Doctoral dissertation]. Rutgers University; 2016. [cited 2021 Apr 18]. Available from: https://rucore.libraries.rutgers.edu/rutgers-lib/50236/.

Council of Science Editors:

Tsai, Pei-Chin 1. Development of three dimensional human skin equivalents based on decellularized extracellular matrices and tyrosine-derived polycarbonate polymers for in-vitro drug screening applications. [Doctoral Dissertation]. Rutgers University; 2016. Available from: https://rucore.libraries.rutgers.edu/rutgers-lib/50236/

16. Treiber, Danielle N. Is It Who Am I or Who Do You Think I Am? Identity Development of Adolescents With Substance Use Disorders.

Degree: PhD, Leadership and Change, 2019, Antioch University

 The purpose of this study was to unearth how adolescents with substance use disorders achieve the task of identity formation and the construction of self-concept… (more)

Subjects/Keywords: Behavioral Sciences; Behavioral Psychology; Clinical Psychology; Counseling Education; Curriculum Development; Criminology; Demographics; Developmental Psychology; Early Childhood Education; Education Policy; Educational Leadership; Health Care; Mental Health; Pharmacology; Personality Psychology; Psychotherapy; Public Health; Public Health Education; Public Policy; Social Work; Teacher Education; Therapy; Families and Family Life; Adolescence; Youth; Development; Identity; Self; Self-Concept; Substance Use; Substance Use Disorders; Drug use; Drug Culture; Addiction Culture; Leadership; Qualitative; Grounded Theory; Situational Analysis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Treiber, D. N. (2019). Is It Who Am I or Who Do You Think I Am? Identity Development of Adolescents With Substance Use Disorders. (Doctoral Dissertation). Antioch University. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=antioch1561825820386228

Chicago Manual of Style (16th Edition):

Treiber, Danielle N. “Is It Who Am I or Who Do You Think I Am? Identity Development of Adolescents With Substance Use Disorders.” 2019. Doctoral Dissertation, Antioch University. Accessed April 18, 2021. http://rave.ohiolink.edu/etdc/view?acc_num=antioch1561825820386228.

MLA Handbook (7th Edition):

Treiber, Danielle N. “Is It Who Am I or Who Do You Think I Am? Identity Development of Adolescents With Substance Use Disorders.” 2019. Web. 18 Apr 2021.

Vancouver:

Treiber DN. Is It Who Am I or Who Do You Think I Am? Identity Development of Adolescents With Substance Use Disorders. [Internet] [Doctoral dissertation]. Antioch University; 2019. [cited 2021 Apr 18]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=antioch1561825820386228.

Council of Science Editors:

Treiber DN. Is It Who Am I or Who Do You Think I Am? Identity Development of Adolescents With Substance Use Disorders. [Doctoral Dissertation]. Antioch University; 2019. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=antioch1561825820386228


Kyoto University / 京都大学

17. Asada, Ryuta. Analysis of new drugs whose clinical development and regulatory approval were hampered during their introduction in Japan : 日本における新医薬品の開発及び承認審査段階におけるハードルの検討.

Degree: 博士(医学), 2014, Kyoto University / 京都大学

新制・論文博士

乙第12801号

論医博第2073号

Subjects/Keywords: clinical data package; clinical trial designs; drug development failures; new drug applications

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Asada, R. (2014). Analysis of new drugs whose clinical development and regulatory approval were hampered during their introduction in Japan : 日本における新医薬品の開発及び承認審査段階におけるハードルの検討. (Thesis). Kyoto University / 京都大学. Retrieved from http://hdl.handle.net/2433/185190 ; http://dx.doi.org/10.14989/doctor.r12801

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Asada, Ryuta. “Analysis of new drugs whose clinical development and regulatory approval were hampered during their introduction in Japan : 日本における新医薬品の開発及び承認審査段階におけるハードルの検討.” 2014. Thesis, Kyoto University / 京都大学. Accessed April 18, 2021. http://hdl.handle.net/2433/185190 ; http://dx.doi.org/10.14989/doctor.r12801.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Asada, Ryuta. “Analysis of new drugs whose clinical development and regulatory approval were hampered during their introduction in Japan : 日本における新医薬品の開発及び承認審査段階におけるハードルの検討.” 2014. Web. 18 Apr 2021.

Vancouver:

Asada R. Analysis of new drugs whose clinical development and regulatory approval were hampered during their introduction in Japan : 日本における新医薬品の開発及び承認審査段階におけるハードルの検討. [Internet] [Thesis]. Kyoto University / 京都大学; 2014. [cited 2021 Apr 18]. Available from: http://hdl.handle.net/2433/185190 ; http://dx.doi.org/10.14989/doctor.r12801.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Asada R. Analysis of new drugs whose clinical development and regulatory approval were hampered during their introduction in Japan : 日本における新医薬品の開発及び承認審査段階におけるハードルの検討. [Thesis]. Kyoto University / 京都大学; 2014. Available from: http://hdl.handle.net/2433/185190 ; http://dx.doi.org/10.14989/doctor.r12801

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Kyoto University

18. Asada, Ryuta. Analysis of new drugs whose clinical development and regulatory approval were hampered during their introduction in Japan .

Degree: 2014, Kyoto University

Subjects/Keywords: clinical data package; clinical trial designs; drug development failures; new drug applications

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Asada, R. (2014). Analysis of new drugs whose clinical development and regulatory approval were hampered during their introduction in Japan . (Thesis). Kyoto University. Retrieved from http://hdl.handle.net/2433/185190

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Asada, Ryuta. “Analysis of new drugs whose clinical development and regulatory approval were hampered during their introduction in Japan .” 2014. Thesis, Kyoto University. Accessed April 18, 2021. http://hdl.handle.net/2433/185190.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Asada, Ryuta. “Analysis of new drugs whose clinical development and regulatory approval were hampered during their introduction in Japan .” 2014. Web. 18 Apr 2021.

Vancouver:

Asada R. Analysis of new drugs whose clinical development and regulatory approval were hampered during their introduction in Japan . [Internet] [Thesis]. Kyoto University; 2014. [cited 2021 Apr 18]. Available from: http://hdl.handle.net/2433/185190.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Asada R. Analysis of new drugs whose clinical development and regulatory approval were hampered during their introduction in Japan . [Thesis]. Kyoto University; 2014. Available from: http://hdl.handle.net/2433/185190

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Texas Medical Center

19. Pan, Haitao. NOVEL BAYESIAN ADAPTIVE CLINICAL TRIAL DESIGNS IN EARLY PHASES.

Degree: PhD, 2017, Texas Medical Center

Early phase, or phase I and phase II, trials are the first step in testing new medicines that have been developed in the lab.… (more)

Subjects/Keywords: Early phase adaptive clinical trial design; BMA-CRM design; Bridging Study; Bayesian Biosimilar Design; Calibrated Power Prior; Biostatistics; Clinical Trials; Medicine and Health Sciences; Statistical Methodology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pan, H. (2017). NOVEL BAYESIAN ADAPTIVE CLINICAL TRIAL DESIGNS IN EARLY PHASES. (Doctoral Dissertation). Texas Medical Center. Retrieved from https://digitalcommons.library.tmc.edu/utgsbs_dissertations/788

Chicago Manual of Style (16th Edition):

Pan, Haitao. “NOVEL BAYESIAN ADAPTIVE CLINICAL TRIAL DESIGNS IN EARLY PHASES.” 2017. Doctoral Dissertation, Texas Medical Center. Accessed April 18, 2021. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/788.

MLA Handbook (7th Edition):

Pan, Haitao. “NOVEL BAYESIAN ADAPTIVE CLINICAL TRIAL DESIGNS IN EARLY PHASES.” 2017. Web. 18 Apr 2021.

Vancouver:

Pan H. NOVEL BAYESIAN ADAPTIVE CLINICAL TRIAL DESIGNS IN EARLY PHASES. [Internet] [Doctoral dissertation]. Texas Medical Center; 2017. [cited 2021 Apr 18]. Available from: https://digitalcommons.library.tmc.edu/utgsbs_dissertations/788.

Council of Science Editors:

Pan H. NOVEL BAYESIAN ADAPTIVE CLINICAL TRIAL DESIGNS IN EARLY PHASES. [Doctoral Dissertation]. Texas Medical Center; 2017. Available from: https://digitalcommons.library.tmc.edu/utgsbs_dissertations/788


University of Utah

20. Guo, Jeremy. Rapid throughput solubility screening assay development and its applications in preformulation;.

Degree: PhD, Pharmaceutics & Pharmaceutical Chemistry;, 2007, University of Utah

Drug solubility is an important physicochemical property for orally administered drugs because it can significantly influence drug dissolution and absorption profiles. Investigative drugs need to… (more)

Subjects/Keywords: Analysis; Drug Development; Drug Solubility

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Guo, J. (2007). Rapid throughput solubility screening assay development and its applications in preformulation;. (Doctoral Dissertation). University of Utah. Retrieved from http://content.lib.utah.edu/cdm/singleitem/collection/etd1/id/137/rec/1072

Chicago Manual of Style (16th Edition):

Guo, Jeremy. “Rapid throughput solubility screening assay development and its applications in preformulation;.” 2007. Doctoral Dissertation, University of Utah. Accessed April 18, 2021. http://content.lib.utah.edu/cdm/singleitem/collection/etd1/id/137/rec/1072.

MLA Handbook (7th Edition):

Guo, Jeremy. “Rapid throughput solubility screening assay development and its applications in preformulation;.” 2007. Web. 18 Apr 2021.

Vancouver:

Guo J. Rapid throughput solubility screening assay development and its applications in preformulation;. [Internet] [Doctoral dissertation]. University of Utah; 2007. [cited 2021 Apr 18]. Available from: http://content.lib.utah.edu/cdm/singleitem/collection/etd1/id/137/rec/1072.

Council of Science Editors:

Guo J. Rapid throughput solubility screening assay development and its applications in preformulation;. [Doctoral Dissertation]. University of Utah; 2007. Available from: http://content.lib.utah.edu/cdm/singleitem/collection/etd1/id/137/rec/1072


University of Oulu

21. Pakanen, M. (Minna). Visual design examples in the evaluation of anticipated user experience at the early phases of research and development.

Degree: 2015, University of Oulu

Abstract User experience research has focused mainly on understanding user experiences during or directly after use. However, studies that focus on anticipated user experiences are… (more)

Subjects/Keywords: anticipated user experience; early development phase; user evaluation; user interfaces; visual design; ennakoitu käyttäjäkokemus; käyttäjäevaluointi; käyttöliittymät; tuotekehityksen alkuvaihe; visuaalinen muotoilu

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pakanen, M. (. (2015). Visual design examples in the evaluation of anticipated user experience at the early phases of research and development. (Doctoral Dissertation). University of Oulu. Retrieved from http://urn.fi/urn:isbn:9789526210605

Chicago Manual of Style (16th Edition):

Pakanen, M (Minna). “Visual design examples in the evaluation of anticipated user experience at the early phases of research and development.” 2015. Doctoral Dissertation, University of Oulu. Accessed April 18, 2021. http://urn.fi/urn:isbn:9789526210605.

MLA Handbook (7th Edition):

Pakanen, M (Minna). “Visual design examples in the evaluation of anticipated user experience at the early phases of research and development.” 2015. Web. 18 Apr 2021.

Vancouver:

Pakanen M(. Visual design examples in the evaluation of anticipated user experience at the early phases of research and development. [Internet] [Doctoral dissertation]. University of Oulu; 2015. [cited 2021 Apr 18]. Available from: http://urn.fi/urn:isbn:9789526210605.

Council of Science Editors:

Pakanen M(. Visual design examples in the evaluation of anticipated user experience at the early phases of research and development. [Doctoral Dissertation]. University of Oulu; 2015. Available from: http://urn.fi/urn:isbn:9789526210605


University of KwaZulu-Natal

22. Chiliza, Hypesia Zamile. Facilitating creative arts teaching and learning with Foundation Phase Teachers : a subject advisor's self-study.

Degree: Education, 2015, University of KwaZulu-Natal

 The purpose of my self-study research was to explore how I as a Department of Basic Education subject advisor could better support Foundation Phase teachers… (more)

Subjects/Keywords: Education.; Foundation Phase Teachers.; Child development.; Art – Study and teaching (Early childhood).; Creative thinking in children.; Elementary school teaching.

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chiliza, H. Z. (2015). Facilitating creative arts teaching and learning with Foundation Phase Teachers : a subject advisor's self-study. (Thesis). University of KwaZulu-Natal. Retrieved from http://hdl.handle.net/10413/13666

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Chiliza, Hypesia Zamile. “Facilitating creative arts teaching and learning with Foundation Phase Teachers : a subject advisor's self-study.” 2015. Thesis, University of KwaZulu-Natal. Accessed April 18, 2021. http://hdl.handle.net/10413/13666.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Chiliza, Hypesia Zamile. “Facilitating creative arts teaching and learning with Foundation Phase Teachers : a subject advisor's self-study.” 2015. Web. 18 Apr 2021.

Vancouver:

Chiliza HZ. Facilitating creative arts teaching and learning with Foundation Phase Teachers : a subject advisor's self-study. [Internet] [Thesis]. University of KwaZulu-Natal; 2015. [cited 2021 Apr 18]. Available from: http://hdl.handle.net/10413/13666.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Chiliza HZ. Facilitating creative arts teaching and learning with Foundation Phase Teachers : a subject advisor's self-study. [Thesis]. University of KwaZulu-Natal; 2015. Available from: http://hdl.handle.net/10413/13666

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


North-West University

23. Loubser, Annemarie. 'n Ondersoek na lewensvaardigheidsopvoeding in die grondslagfase / Annemarie Loubser .

Degree: 2010, North-West University

 In die Grondslagfase is Lewensvaardighede een van drie leerprogramme wat deur die Departement van Onderwys voorgeskryf en verder in die Nasionale Kurrikulumverklaring uiteengesit word. Lewensvaardighede… (more)

Subjects/Keywords: Life skills; Foundation phase; Life orientation; Observation; Education of life skills; Outcomes based education; National curriculum policy; Assessment; Early childhood development

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Loubser, A. (2010). 'n Ondersoek na lewensvaardigheidsopvoeding in die grondslagfase / Annemarie Loubser . (Thesis). North-West University. Retrieved from http://hdl.handle.net/10394/4957

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Loubser, Annemarie. “'n Ondersoek na lewensvaardigheidsopvoeding in die grondslagfase / Annemarie Loubser .” 2010. Thesis, North-West University. Accessed April 18, 2021. http://hdl.handle.net/10394/4957.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Loubser, Annemarie. “'n Ondersoek na lewensvaardigheidsopvoeding in die grondslagfase / Annemarie Loubser .” 2010. Web. 18 Apr 2021.

Vancouver:

Loubser A. 'n Ondersoek na lewensvaardigheidsopvoeding in die grondslagfase / Annemarie Loubser . [Internet] [Thesis]. North-West University; 2010. [cited 2021 Apr 18]. Available from: http://hdl.handle.net/10394/4957.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Loubser A. 'n Ondersoek na lewensvaardigheidsopvoeding in die grondslagfase / Annemarie Loubser . [Thesis]. North-West University; 2010. Available from: http://hdl.handle.net/10394/4957

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

24. Santhosh Kumar, Harish. Front-loading short CFD loops to integrate with engineering template .

Degree: Chalmers tekniska högskola / Institutionen för industri- och materialvetenskap, 2020, Chalmers University of Technology

 In this competitive and fast evolving automotive market, it is crucial to progress forward in the product development process effectively and efficiently. One tool to… (more)

Subjects/Keywords: Engineering Template, Simulation, CFD integration, Short loops; Early product development phase, Simulation and knowledge based design

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Santhosh Kumar, H. (2020). Front-loading short CFD loops to integrate with engineering template . (Thesis). Chalmers University of Technology. Retrieved from http://hdl.handle.net/20.500.12380/301785

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Santhosh Kumar, Harish. “Front-loading short CFD loops to integrate with engineering template .” 2020. Thesis, Chalmers University of Technology. Accessed April 18, 2021. http://hdl.handle.net/20.500.12380/301785.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Santhosh Kumar, Harish. “Front-loading short CFD loops to integrate with engineering template .” 2020. Web. 18 Apr 2021.

Vancouver:

Santhosh Kumar H. Front-loading short CFD loops to integrate with engineering template . [Internet] [Thesis]. Chalmers University of Technology; 2020. [cited 2021 Apr 18]. Available from: http://hdl.handle.net/20.500.12380/301785.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Santhosh Kumar H. Front-loading short CFD loops to integrate with engineering template . [Thesis]. Chalmers University of Technology; 2020. Available from: http://hdl.handle.net/20.500.12380/301785

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Louisville

25. Ray, Herman E. Design and inference in phase II/III clinical trials incorporating monitoring of multiple endpoints.

Degree: PhD, 2011, University of Louisville

 The phase II clinical trial is a critical step in the drug development process. In the oncology setting, phase II studies typically evaluate one primary… (more)

Subjects/Keywords: Clinical trial; Bivariate; Phase II; Phase III

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ray, H. E. (2011). Design and inference in phase II/III clinical trials incorporating monitoring of multiple endpoints. (Doctoral Dissertation). University of Louisville. Retrieved from 10.18297/etd/1189 ; https://ir.library.louisville.edu/etd/1189

Chicago Manual of Style (16th Edition):

Ray, Herman E. “Design and inference in phase II/III clinical trials incorporating monitoring of multiple endpoints.” 2011. Doctoral Dissertation, University of Louisville. Accessed April 18, 2021. 10.18297/etd/1189 ; https://ir.library.louisville.edu/etd/1189.

MLA Handbook (7th Edition):

Ray, Herman E. “Design and inference in phase II/III clinical trials incorporating monitoring of multiple endpoints.” 2011. Web. 18 Apr 2021.

Vancouver:

Ray HE. Design and inference in phase II/III clinical trials incorporating monitoring of multiple endpoints. [Internet] [Doctoral dissertation]. University of Louisville; 2011. [cited 2021 Apr 18]. Available from: 10.18297/etd/1189 ; https://ir.library.louisville.edu/etd/1189.

Council of Science Editors:

Ray HE. Design and inference in phase II/III clinical trials incorporating monitoring of multiple endpoints. [Doctoral Dissertation]. University of Louisville; 2011. Available from: 10.18297/etd/1189 ; https://ir.library.louisville.edu/etd/1189


University of Texas – Austin

26. -6087-3634. Assessment of the clinical utility of pharmacogenomic testing on drug utilization in a high-risk patient population : an interim analysis using the upgrade registry.

Degree: PhD, Pharmaceutical sciences, 2016, University of Texas – Austin

 The potential benefits of incorporating pharmacogenomic (PGx) testing into clinical practice include minimizing adverse drug reactions (ADRs) and improving clinical outcomes based on genetic differences… (more)

Subjects/Keywords: Pharmacogenomics; Clinical utility; Drug utilization

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

-6087-3634. (2016). Assessment of the clinical utility of pharmacogenomic testing on drug utilization in a high-risk patient population : an interim analysis using the upgrade registry. (Doctoral Dissertation). University of Texas – Austin. Retrieved from http://hdl.handle.net/2152/41982

Note: this citation may be lacking information needed for this citation format:
Author name may be incomplete

Chicago Manual of Style (16th Edition):

-6087-3634. “Assessment of the clinical utility of pharmacogenomic testing on drug utilization in a high-risk patient population : an interim analysis using the upgrade registry.” 2016. Doctoral Dissertation, University of Texas – Austin. Accessed April 18, 2021. http://hdl.handle.net/2152/41982.

Note: this citation may be lacking information needed for this citation format:
Author name may be incomplete

MLA Handbook (7th Edition):

-6087-3634. “Assessment of the clinical utility of pharmacogenomic testing on drug utilization in a high-risk patient population : an interim analysis using the upgrade registry.” 2016. Web. 18 Apr 2021.

Note: this citation may be lacking information needed for this citation format:
Author name may be incomplete

Vancouver:

-6087-3634. Assessment of the clinical utility of pharmacogenomic testing on drug utilization in a high-risk patient population : an interim analysis using the upgrade registry. [Internet] [Doctoral dissertation]. University of Texas – Austin; 2016. [cited 2021 Apr 18]. Available from: http://hdl.handle.net/2152/41982.

Note: this citation may be lacking information needed for this citation format:
Author name may be incomplete

Council of Science Editors:

-6087-3634. Assessment of the clinical utility of pharmacogenomic testing on drug utilization in a high-risk patient population : an interim analysis using the upgrade registry. [Doctoral Dissertation]. University of Texas – Austin; 2016. Available from: http://hdl.handle.net/2152/41982

Note: this citation may be lacking information needed for this citation format:
Author name may be incomplete


University of Wisconsin – La Cross

27. Ladell, Peter. Isolation and characterization of antibiotics produced by the nematode symbiont Xenorhabdus szentirmaii.

Degree: 2011, University of Wisconsin – La Cross

 Each year, it is estimated that 1.7 million healthcare-acquired infections occur in the United States with 70% of the bacteria causing these infections being resistant… (more)

Subjects/Keywords: Antibiotics; Drug development

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ladell, P. (2011). Isolation and characterization of antibiotics produced by the nematode symbiont Xenorhabdus szentirmaii. (Thesis). University of Wisconsin – La Cross. Retrieved from http://digital.library.wisc.edu/1793/54691

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Ladell, Peter. “Isolation and characterization of antibiotics produced by the nematode symbiont Xenorhabdus szentirmaii.” 2011. Thesis, University of Wisconsin – La Cross. Accessed April 18, 2021. http://digital.library.wisc.edu/1793/54691.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Ladell, Peter. “Isolation and characterization of antibiotics produced by the nematode symbiont Xenorhabdus szentirmaii.” 2011. Web. 18 Apr 2021.

Vancouver:

Ladell P. Isolation and characterization of antibiotics produced by the nematode symbiont Xenorhabdus szentirmaii. [Internet] [Thesis]. University of Wisconsin – La Cross; 2011. [cited 2021 Apr 18]. Available from: http://digital.library.wisc.edu/1793/54691.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Ladell P. Isolation and characterization of antibiotics produced by the nematode symbiont Xenorhabdus szentirmaii. [Thesis]. University of Wisconsin – La Cross; 2011. Available from: http://digital.library.wisc.edu/1793/54691

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Western Kentucky University

28. Binford, Lauren A. Impact of a Teacher Training Program to Increase Informative Praise and Decrease Commands and Negative Comments.

Degree: Specialist in Education, Department of Psychology, 2015, Western Kentucky University

  Research has found that many children who come from a low socioeconomic background often begin their schooling careers behind most students. Head Start programs… (more)

Subjects/Keywords: professional development; Head Start; informative praise statements; Clinical Psychology; Pre-Elementary, Early Childhood, Kindergarten Teacher Education; Psychology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Binford, L. A. (2015). Impact of a Teacher Training Program to Increase Informative Praise and Decrease Commands and Negative Comments. (Masters Thesis). Western Kentucky University. Retrieved from https://digitalcommons.wku.edu/theses/1530

Chicago Manual of Style (16th Edition):

Binford, Lauren A. “Impact of a Teacher Training Program to Increase Informative Praise and Decrease Commands and Negative Comments.” 2015. Masters Thesis, Western Kentucky University. Accessed April 18, 2021. https://digitalcommons.wku.edu/theses/1530.

MLA Handbook (7th Edition):

Binford, Lauren A. “Impact of a Teacher Training Program to Increase Informative Praise and Decrease Commands and Negative Comments.” 2015. Web. 18 Apr 2021.

Vancouver:

Binford LA. Impact of a Teacher Training Program to Increase Informative Praise and Decrease Commands and Negative Comments. [Internet] [Masters thesis]. Western Kentucky University; 2015. [cited 2021 Apr 18]. Available from: https://digitalcommons.wku.edu/theses/1530.

Council of Science Editors:

Binford LA. Impact of a Teacher Training Program to Increase Informative Praise and Decrease Commands and Negative Comments. [Masters Thesis]. Western Kentucky University; 2015. Available from: https://digitalcommons.wku.edu/theses/1530

29. Giannitelli, Marianna. Schizophrénies à début précoce : caractérisation clinique via une approche développementale et dimensionnelle : Early-onset schizophrenias : clinical characterization by developmental and dimensional approach.

Degree: Docteur es, Neurosciences, 2016, Université Pierre et Marie Curie – Paris VI

: la schizophrénie à début précoce (SDP) est un syndrome rare invalidant peu étudié. Dans ce travail, nos objectifs sont: de caractériser de profils cliniques… (more)

Subjects/Keywords: Schizophrénies à début précoce; Organicité; Caractérisation; Neuro-développement; Susceptibilité génétique; Reconnaissance émotionnelle; Early Onset Schizophrenia (EOS); Clinical caracterization; Neuro-development; 616.89

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Giannitelli, M. (2016). Schizophrénies à début précoce : caractérisation clinique via une approche développementale et dimensionnelle : Early-onset schizophrenias : clinical characterization by developmental and dimensional approach. (Doctoral Dissertation). Université Pierre et Marie Curie – Paris VI. Retrieved from http://www.theses.fr/2016PA066621

Chicago Manual of Style (16th Edition):

Giannitelli, Marianna. “Schizophrénies à début précoce : caractérisation clinique via une approche développementale et dimensionnelle : Early-onset schizophrenias : clinical characterization by developmental and dimensional approach.” 2016. Doctoral Dissertation, Université Pierre et Marie Curie – Paris VI. Accessed April 18, 2021. http://www.theses.fr/2016PA066621.

MLA Handbook (7th Edition):

Giannitelli, Marianna. “Schizophrénies à début précoce : caractérisation clinique via une approche développementale et dimensionnelle : Early-onset schizophrenias : clinical characterization by developmental and dimensional approach.” 2016. Web. 18 Apr 2021.

Vancouver:

Giannitelli M. Schizophrénies à début précoce : caractérisation clinique via une approche développementale et dimensionnelle : Early-onset schizophrenias : clinical characterization by developmental and dimensional approach. [Internet] [Doctoral dissertation]. Université Pierre et Marie Curie – Paris VI; 2016. [cited 2021 Apr 18]. Available from: http://www.theses.fr/2016PA066621.

Council of Science Editors:

Giannitelli M. Schizophrénies à début précoce : caractérisation clinique via une approche développementale et dimensionnelle : Early-onset schizophrenias : clinical characterization by developmental and dimensional approach. [Doctoral Dissertation]. Université Pierre et Marie Curie – Paris VI; 2016. Available from: http://www.theses.fr/2016PA066621

30. Kalkman, S. Pragmatic randomized trials with new interventions : An ethical analysis.

Degree: 2017, University Utrecht

 Randomized controlled clinical trials (RCTs) are considered fundamental to the optimization of health care decision-making. Today, the drug development and evaluation process is dominated by… (more)

Subjects/Keywords: research ethics; clinical trials; drug development; real world evidence

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kalkman, S. (2017). Pragmatic randomized trials with new interventions : An ethical analysis. (Doctoral Dissertation). University Utrecht. Retrieved from http://dspace.library.uu.nl/handle/1874/345859 ; URN:NBN:NL:UI:10-1874-345859 ; urn:isbn:978-90-393-6709-4 ; URN:NBN:NL:UI:10-1874-345859 ; http://dspace.library.uu.nl/handle/1874/345859

Chicago Manual of Style (16th Edition):

Kalkman, S. “Pragmatic randomized trials with new interventions : An ethical analysis.” 2017. Doctoral Dissertation, University Utrecht. Accessed April 18, 2021. http://dspace.library.uu.nl/handle/1874/345859 ; URN:NBN:NL:UI:10-1874-345859 ; urn:isbn:978-90-393-6709-4 ; URN:NBN:NL:UI:10-1874-345859 ; http://dspace.library.uu.nl/handle/1874/345859.

MLA Handbook (7th Edition):

Kalkman, S. “Pragmatic randomized trials with new interventions : An ethical analysis.” 2017. Web. 18 Apr 2021.

Vancouver:

Kalkman S. Pragmatic randomized trials with new interventions : An ethical analysis. [Internet] [Doctoral dissertation]. University Utrecht; 2017. [cited 2021 Apr 18]. Available from: http://dspace.library.uu.nl/handle/1874/345859 ; URN:NBN:NL:UI:10-1874-345859 ; urn:isbn:978-90-393-6709-4 ; URN:NBN:NL:UI:10-1874-345859 ; http://dspace.library.uu.nl/handle/1874/345859.

Council of Science Editors:

Kalkman S. Pragmatic randomized trials with new interventions : An ethical analysis. [Doctoral Dissertation]. University Utrecht; 2017. Available from: http://dspace.library.uu.nl/handle/1874/345859 ; URN:NBN:NL:UI:10-1874-345859 ; urn:isbn:978-90-393-6709-4 ; URN:NBN:NL:UI:10-1874-345859 ; http://dspace.library.uu.nl/handle/1874/345859

[1] [2] [3] [4] [5] … [4319]

.